Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

29.05.2018 | original article | Ausgabe 11-12/2018

Wiener klinische Wochenschrift 11-12/2018

Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease

Wiener klinische Wochenschrift > Ausgabe 11-12/2018
Jianmei Zhang, Wenbin Chen, Li Fang, Qiu Li, Xu Zhang, Haiqing Zhang, Qingbo Guan, Rang Zhao, Chongbo Yang, Fei Jing


Nonalcoholic fatty liver disease (NAFLD) currently represents the most common hepatic disease worldwide and is closely linked to cardiovascular disease, obesity and diabetes mellitus. This study aimed to investigate NAFLD and its influence on different monocyte subpopulations to determine the presence of significant associations. A total of 3 monocyte subpopulations were investigated, i.e. classical (CD14++CD16−), intermediate (CD14++CD16+) and non-classical (CD14+CD16++). Of the participants 261 were included in this study (n = 53 with NAFLD, n = 208 controls). Ultrasonography was used to diagnose NAFLD and exclude other morphologic causes of liver diseases and other tests (including medical history inquiries and detection of hepatitis virus) were performed to exclude other causes of parenchymal liver disease. Classical inflammatory and metabolic-related NAFLD biomarkers were also determined. In contrast to the healthy control group, the intermediate monocyte fraction was increased in NAFLD patients (p = 0.032), while the classical monocyte fraction was decreased (p = 0.025). Intermediate monocyte fraction, body mass index (BMI) and tumor necrosis factor alpha (TNF-α) were independent risk factors for NAFLD. Classical, non-classical and intermediate monocytes fraction were strongly associated with age, triglyceride, and waist circumference. This study suggests that the intermediate monocyte fraction in peripheral blood is likely related to the aggravation of NAFLD.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 11-12/2018

Wiener klinische Wochenschrift 11-12/2018 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien


MUW researcher of the month

MUW researcher of the month